Hoʻololi Peptide
Nā Peptides Stapled
He aha ka Stapled Peptides?
Ua hōʻike ʻia nā haʻawina e hiki i nā peptides me ka α-helical structure a waiwai i ka uku maikaʻi ke hele i nā membrane cell. Eia naʻe, i kaawale mai ke kino makua, ʻAʻole hiki i ka peptide ke mālama i kona ʻano kumu lua, a ʻo ka conformational instability alakaʻi i ka nāwaliwali o kona paʻa ʻana i nā protein, ʻoiai ʻaʻole hiki i nā peptides laina maʻamau ke hele i ka membrane cell a maʻalahi ka hydrolysed. Ma hope o nā ho'āʻo mau, ʻO Verdine et al. ua kūkulu ʻia kahi ʻano hou o ka peptide, kapa ʻia kēia peptide peptide stapled, he scaffold kalapona a pau me ka α-helical, hoʻopaʻa ʻia ka scaffold-carbon a pau i ka hana α-helical, ka mea e hoʻoikaika i ka pilina ma waena o nā molekele peptide a me nā protein, a hiki i ka peptide stapled ke hele i ka membrane cell a ʻaʻole maʻalahi ka hydrolysed, ʻoi aku ka kiʻekiʻe o ka hana pharmacological i hoʻohālikelike ʻia me nā lāʻau liʻiliʻi liʻiliʻi ma mua a me nā lāʻau i hoʻokumu ʻia i ka protein. ʻoi aku ka nui o ka hana pharmacological ma mua o nā lāʻau mole liʻiliʻi a me nā lāʻau protein.
ʻepekema Stapled Peptides
ʻO ka ʻokoʻa ma waena o ka synthesis o ka peptide stapled a me ka synthesis peptide maʻamau aia i ka hoʻokomo ʻana i ʻelua mau amino amino kūlohelohe ʻole i loaʻa nā pūʻulu α-methyl a me α-alkenyl i ka wā paʻa-phase synthesis o ke kaulahao peptide., a laila, hiki mai ka hopena decomposition paʻakikī olefinic ma waena o nā ʻakika amino kūlohelohe ʻelua e hana i kahi scaffold kalapona āpau me ka hoʻohālikelike α-helical paʻa., a laila synthesize i ka peptide stapled.

Kemika Peptide Stapled
ʻO ka hanauna mua Grubbs catalyst (hema) me ka tricyclohexylphosphine (PCy3) ʻO nā ligands a me ke kalapona carbene i hoʻonohonoho ʻia he wahi paʻa ruthenium paʻa i hoʻohana ʻia no ka metathesis olefin i nā peptides.. ʻO nā noiʻi ma hope i alakaʻi ʻia i ka hoʻolālā ʻana i kahi mea hoʻoheheʻe Grubbs lua-hanau. (waena). He 3rd generation catalyst, ʻike ʻia hoʻi ʻo ka Hoveyda–Grubbs catalyst (akau), pani i ka N-heterocyclic carbene ligand no nā ligand benzylidene i loaʻa kahi hui ortho-isopropoxy chelating i hoʻopili ʻia i ke apo benzene..

Hoʻokahi stapled peptide pane
Hoʻokahi stapled peptide pane. ʻO ka hoʻohui ʻana o ʻelua alpha-4-n-pentenylalanine (S5) ʻO nā koena i loko o kahi kaula peptide hiki ke hoʻopaʻa i ke apo metathesis (ʻo ia hoʻi., Pane ʻo Grubbs) e hana i hoʻokahi peptide stapled. Ke n = 3 (ʻo ia hoʻi. me 3 nā amino acids ma waena o nā koena S5) ʻike ʻia ke ʻano kumu he i, i + 4.

Hoʻonohonoho hoʻonohonoho hoʻokahi
ʻO ke kūlana kiʻekiʻe a me ka maʻalahi o ka hopena "click". (Huisgen 1,3-dipolar cycloaddition hopena) hui pū ʻia me ka maʻalahi o ka synthesis o nā waikawa amino pono ʻole, hiki i ka hana maʻalahi o nā peptides triazole-stapled. ʻo kahi laʻana, kahi hui o L- Hiki (εN3) a me D-Pra (D-propargylalanine) hiki ke hoʻohana ʻia no ka hana ʻana i nā peptides triazole-stapled hoʻokahi..
Kuhikuhi Manawa
Nā lula hoʻolālā no nā peptides stapled me ka hana in vivo a me kā lākou noi ʻana i nā antagonists Mdm2/X.
ʻOiai hiki i nā peptides α-helical stapled ke hoʻoponopono i nā pahuhopu paʻakikī, Ua pale ʻia ko lākou holomua ʻana e ka ʻike maikaʻi ʻole no ka hoʻolilo ʻana iā lākou i nā cell permeable me ka pale ʻana i nā mea ʻino. Ma ka synthesizing >350 nā molekala, hōʻike mākou i nā kahe hana no ka ʻike ʻana i nā peptides stapled e kūʻē iā Mdm2(X) me ka hana in vivo a ʻaʻohe hopena o waho. Loaʻa i nā ʻike koʻikoʻi kahi pilina ma waena o ka lipophilicity a me ka permeability, ka wehe ʻana i ka hoʻopiʻi maikaʻi e pale aku i nā mea ʻawaʻawa, hoʻokomo pono i ke koena anionic e hoʻonui i ka solubility/ʻano, ka optimization o ka C-terminal lōʻihi / helicity e hoʻonui i ka mana, a me ka optimization o staple type/helu e pale aku i ka polypharmacology. Hāʻawi ka palapala hana hana i nā peptides me >292x i hoʻomaikaʻi ʻia i ka hoʻonui ʻia ʻana o ke kelepona a ʻaʻohe hopena o ka hoʻonui ʻia ʻana o ke kelepona ( > 3800x ma ka pahu kuhikuhi). Ka hoʻohana ʻana i kēia mau 'ōlelo hoʻolālā' i kahi Mdm2 ʻokoʻa(X) Hoʻonui ka peptide series ( > 150x) hiki ke hoʻopau i nā mea ʻawaʻawa. Pono ke kaʻina hana i wehewehe ʻia e maʻalahi i nā hopena therapeutic, no kēlā mau pahuhopu e like me Mdm2(X) Loaʻa nā pilina hydrophobic a hiki ke hoʻopaʻa ʻia me kahi kumu helical.
Nā lawelawe hoʻololi peptide pili
peptide glycosylation
peptide glycosylation
ʻO ka peptide glycosylation kahi hoʻololi covalent i hiki ke hoʻomaikaʻi i nā waiwai physicochemical o nā peptides.
Heluhelu hou akupeptide Phosphorylation
peptide Phosphorylation
Hiki mai paha ka Phosphoralation ma Serine (S, E lilo), Threonine (Ua ʻōlelo ʻo T, ʻO Thr) a me Tyrosine (Y, ʻO Tyr) nā kaulahao ʻaoʻao e ka hoʻokumu ʻana i ka paʻa phosphoester
Heluhelu hou akuNā Peptides Stapled
Nā Peptides Stapled
ʻO ka hoʻolauna ʻana i ʻelua mau waikawa amino kūlohelohe i loaʻa ka α-methyl, Nā pūʻulu α-alkenyl i ka wā paʻa-phase synthesis o nā kaulahao peptide.
Heluhelu hou akuCyclic Peptide
Cyclic Peptide
Hoʻonui ka cyclization i ka conformational stability o nā peptides (pili i kā lākou mau analogues linear) a he hoʻolālā maʻamau i ka hoʻomohala ʻana i ka peptide.
Heluhelu hou akuhoʻololi peptide
ʻIke nui i ka hoʻololi peptide, hāʻawi i nā ala kūpono he nui no ka noiʻi peptide.